oa Prevalence of Hepatitis Virus Infection and Immunogenicity of HBV Vaccine in Children with Down's Syndrome

References

1. Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunolo-gical features of Downs syndrome: A review. J Intellect Disabil Res. 1993 Dec; 37:Pt 6:543–551.
   [Google الباحث العلمي]
2. Oda M, Hakamada R, Ono K, Higurashi M. A seroimmunolo-gical analysis of Down's syndrome. Gerontology. 1993; 39:Suppl 1:16–23.
   [Google الباحث العلمي]
3. Cuadrado E, Barrena MJ. Immune dysfunction in Down 5 syndrome: primary immune deficiency or early senescence of the immune system. Clin Immunol Immunopathol. 1996 Mar; 78:3:209–214.
   [Google الباحث العلمي]
4. Schoub BD, Johnson S, McAnerney JM, Blackburn NK. Hepatitis B virus prevalence in two institutions for the mentally handicapped. S Afr Med J. 1993 Sep; 83:9:650–653.
   [Google الباحث العلمي]
5. Lundig S, Hansen KS, Kragsgaard K, Rosdahl N, Smith G, Wantzin PS. Occurrence of Hepatitis B and C among mentally retarded. UgeskrLaeger. 1999 Aug; 161:31:4393–4396.
   [Google الباحث العلمي]
6. Ahman L, Back E, Bensch K, Ollen P. Non-efficacy of low dose intradermal vaccination against Hepatitis B in Down's syndrome. Scand infectious Dis. 1993; 25:1:16–23.
   [Google الباحث العلمي]
7. Breuer B, Friedman SM, Millner ES, Kane MA, Snyder RH, Maynard JE. Transmission of Hepatitis B virus in classroom contacts of mentally retarded carriers. JAMA. 1985; 245::3190–3195.
   [Google الباحث العلمي]
8. Rua Armesto MJ, Ramirez Marin M. Predisposition of Down's syndrome to chronic infection with Hepatitis B virus. An Esp Pediatr. 1993 Jun; 38:6:529–531.
   [Google الباحث العلمي]
9. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadet-suk S, Sentrakul P, Safary A. Protective efficacy of a recombi-nant DNA Hepatitis B vaccine in neonates of HBe-Antigen positive mothers. JAMA. June 9; 261:22.
   [Google الباحث العلمي]
10. Kuwang-Juei Lo, Shou-Dong Lee, Yang-Te Tsai, Tzee Chung Wu, Cho-Yu Chan, Gran-Hum Chen, Ching-Lan Yeh. Long-term immunogenicity and efficacy of Hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology. 1988; 8:6:1647–1650.
    [Google الباحث العلمي]
11. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics. 1997; 99::351–353.
    [Google الباحث العلمي]
12. Szmuness W, Stevens CE, Harley EJ;, et al., Hepatitis B vaccine: demonstration of efficacy in a controlled trial in a high risk population in the U.S. N Eng J Med. 1980; 303::833–834.
    [Google الباحث العلمي]
13. Bloom B, Hellman A, Fendrick A, et al., reappraisal of Hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann intern Med. 1993; 118::293–306.
    [Google الباحث العلمي]
14. Kane M. Epidemiology of hepatitis B infections in North America. Vaccine. 1995; 13:Suppl 1:516–517.
    [Google الباحث العلمي]
15. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Sem Liv Dis. 1991; 11::84–92.
    [Google الباحث العلمي]
16. Centers for Disease control. Hepatitis B virus: a comprehen-sive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendation of the Immunization Practices Advisory Committee (ACIP). MMWR. 1991; 40:No. RR-13:1–25.
    [Google الباحث العلمي]
17. Francis DP, Hadler SC, Thompson SE;, et al., Prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Int Med. 1982; 97::362–366.
    [Google الباحث العلمي]
18. Beasly RP, Hwang LY, Lee GC, et al., Prevention of perinatally transmitted hepatitis B virus with hepatitis B immunoglobulin 1 and hepatitis B vaccine. Lancet. 1983;, 1099-102. j.
    [Google الباحث العلمي]
19. Mahoney F, Woodruff B, Erben J;, et al., Evaluation of a 1 Hepatitis B immunization program on the prevalence of <  hepatitis B virus infection. J infect Dis. 1993; 167::203–207.
    [Google الباحث العلمي]
20. Edmunds W, Medley G, Nikes D. Cost-effectiveness of hepatitis B virus immunization. JAMA. 1982; 97::362–366.
    [Google الباحث العلمي]
21. World Health Organization. Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull WHO. 1988; 66::443–455.
    [Google الباحث العلمي]
22. National Advisory Committee on Immunization. Statement on universal immunization against hepatitis B. Can Dis Wkly rep. 1991; 17::165–171.
    [Google الباحث العلمي]
23. Bell A. Universal hepatitis B immunization: the British Columbia experience. Vaccine. 1995; 13:suppl 1:S77–S81.
    [Google الباحث العلمي]
24.   Report of the working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome. Can MedAssos J. 1993; 149:3:314–319.
    [Google الباحث العلمي]
25. Committee on Infectious Diseases. 1997 Red Book. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics 1997;:18–19.
    [Google الباحث العلمي]
26. Dobs on S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B program. JAMA. 1995; 274::1209–1213.
    [Google الباحث العلمي]
27.   RCPCH. Medicines for Children. 1999 Aug;:266–267.
    [Google الباحث العلمي]
28. Committee on Infectious Diseases. 1997 Red Book. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics 1997:p.255.
    [Google الباحث العلمي]
29. Centers for Disease control. Update on Hepatitis B prevention. MMW. 1987; 36::353–366.
    [Google الباحث العلمي]